SAN DIEGO (AP) _ Organovo Holdings Inc. (ONVO) on Thursday reported a loss of $7.8 million in its fiscal third quarter.
The San Diego-based company said it had a loss of 7 cents per share.
The development-stage company focused on commercializing functional human tissue for drug and biological research posted revenue of $1.2 million in the period.
Organovo expects full-year revenue in the range of $4.5 million to $5.2 million.
In the final minutes of trading on Thursday, the company's shares hit $1.32. A year ago, they were trading at $3.68.
No comments:
Post a Comment